Estrogen Receptor Negative and Progesterone Receptor Positive Breast Carcinomas—How Frequent are they?

By Cserni Gábor  

Pathology & Oncology Research, Vol. 17, Iss. 3, 2011-09 ,pp. : 663-668

Springer Publishing Company

Access to resources Recommend Favorite

S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer

By Bryant J.   Fisher B.   Gündüz N.   Costantino J.P.   Emir B.  

Breast Cancer Research and Treatment, Vol. 51, Iss. 3, 1998-10 ,pp. : 239-253

Springer Publishing Company

Access to resources Recommend Favorite

A model of spontaneous mouse mammary tumor for human estrogen receptor- and progesterone receptor-negative breast cancer

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2241-2249

Spandidos Publications

Access to resources Recommend Favorite

Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer

By Delpech Y.  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 619-627

Springer Publishing Company

Access to resources Recommend Favorite

Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapy

By              

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 303-308

Spandidos Publications

Access to resources Recommend Favorite